Cargando…
Mas Receptor Agonist AVE0991 increases surfactant protein expression under hyperoxic conditions in human lung epithelial cells
BACKGROUND: Hyperoxia in pre-term neonates is a known risk factor of bronchopulmonary dysplasia (BPD). Hyperoxia is known to cause oxidative stress, inflammatory changes that leads to surfactant deactivation, and decreased surfactant expression. The previous research has shown short term exposure to...
Autores principales: | Thiruvenkataramani, Ranga Prasanth, Abdul-Hafez, Amal, Gewolb, Ira, Uhal, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373051/ https://www.ncbi.nlm.nih.gov/pubmed/34414259 |
Ejemplares similares
-
Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury
por: Barroso, Lívia Corrêa, et al.
Publicado: (2012) -
Oxygen injury in neonates: which is worse? hyperoxia, hypoxia, or alternating hyperoxia/hypoxia
por: Mohamed, Tarek, et al.
Publicado: (2020) -
Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
por: Klein, Sabine, et al.
Publicado: (2015) -
Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
por: Omar, Said A., et al.
Publicado: (2022) -
Evaluation of the cardioprotective and antihypertensive effect of AVE 0991 in normotensive and hypertensive rats
por: da Silva, Matheus Vinicius Barbosa, et al.
Publicado: (2022)